Page last updated: 2024-08-24

triazoles and cenicriviroc

triazoles has been researched along with cenicriviroc in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertine, M; Brun-Vézinet, F; Charpentier, C; Collin, G; Damond, F; Descamps, D; Lefebvre, E; Matheron, S; Peytavin, G; Visseaux, B1
Giesler, KE; Kim, MB; Liotta, DC; Tahirovic, YA; Truax, VM; Wilson, LJ1

Reviews

1 review(s) available for triazoles and cenicriviroc

ArticleYear
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV.
    Expert opinion on investigational drugs, 2016, Volume: 25, Issue:12

    Topics: Animals; Anti-HIV Agents; CCR5 Receptor Antagonists; Cyclohexanes; Drug Design; HIV Infections; Humans; Imidazoles; Maraviroc; Sulfoxides; Triazoles

2016

Other Studies

1 other study(ies) available for triazoles and cenicriviroc

ArticleYear
Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates.
    PloS one, 2015, Volume: 10, Issue:8

    Topics: Anti-HIV Agents; CCR5 Receptor Antagonists; Cells, Cultured; Coculture Techniques; Cyclohexanes; HIV Infections; HIV-2; Humans; Imidazoles; Leukocytes, Mononuclear; Maraviroc; Phenotype; Phytohemagglutinins; Receptors, CCR2; Receptors, CCR5; Sulfoxides; Triazoles; Virus Replication

2015